Contributions
555 recent contributions in Hansard
HANSARDCarers: National StrategyAlso, it is challenging for those aged over 85. As I alluded to in my previous answer, GP practices have to be able to identify people in that age range so that they can work with…12 Mar 2024HANSARDCarers: National StrategyThe noble Lord is right, and indeed I have experienced that position myself. If you take a loved one to hospital or to the doctor’s, and the doctor’s surgery has been used to…12 Mar 2024HANSARDCarers: National StrategyMy noble friend is absolutely right and raises an important point. The Department for Education’s new data on young carers, collected through the school census published last…12 Mar 2024HANSARDCarers: National StrategyThe noble Baroness raises a very important point and, as I have already mentioned, the Government have conducted a census looking at the data to identify those carers. Various…12 Mar 2024HANSARDCarers: National StrategyThe right reverend Prelate raises an important point, and we welcomed the report he referred to. The Department for Business and Trade is bringing in a new leave entitlement of…12 Mar 2024HANSARDCarers: National StrategyAs People at the Heart of Care put it in 2021, we set out a strategic approach to empowering unpaid carers, and in October 2023 the Department of Health and Social Care launched…12 Mar 2024HANSARDNon-Domestic Rating (Rates Retention: Miscellaneous Amendments) Regulations 2024My Lords, on behalf of my noble friend Lady Scott of Bybrook, I beg to move the Motion standing in her name on the Order Paper.28 Feb 2024HANSARDNon-Domestic Rating (Rates Retention: Miscellaneous Amendments) Regulations 2024That the draft Regulations laid before the House on 20 February be approved. Considered in Grand Committee on 27 February .28 Feb 2024HANSARDHuman Medicines (Amendments Relating to Coronavirus and Influenza) (England and Wales and Scotland) Regulations 2024That the draft Regulations laid before the House on 10 January be approved. Relevant document: 10th Report from the Secondary Legislation Scrutiny Committee . Considered in Grand…28 Feb 2024HANSARDHuman Medicines (Amendments Relating to Coronavirus and Influenza) (England and Wales and Scotland) Regulations 2024That the Grand Committee do consider the Human Medicines (Amendments Relating to Coronavirus and Influenza) (England and Wales and Scotland) Regulations 2024. Relevant document:…27 Feb 2024HANSARDHuman Medicines (Amendments Relating to Coronavirus and Influenza) (England and Wales and Scotland) Regulations 2024My Lords, I am most grateful to noble Lords; in closing, I thank all noble Lords for participating in this debate. We always have healthy questions and, I hope, answers in this…27 Feb 2024HANSARDHuman Medicines (Amendments Relating to Coronavirus and Influenza) (England and Wales and Scotland) Regulations 2024My Lords, these important regulations were laid before the House on 10 January 2024 and I am grateful to be leading the debate on them. In autumn 2020, in response to the Covid-19…27 Feb 2024HANSARDPneumoconiosis etc. (Workers’ Compensation) (Payment of Claims) (Amendment) Regulations 2024That the draft Regulations laid before the House on 14 December 2023 and 11 January be approved. Considered in Grand Committee on 19 February.21 Feb 2024HANSARDEconomic Activity of Public Bodies (Overseas Matters) BillI remind noble Lords of the seven-minute time limit.20 Feb 2024HANSARDEconomic Activity of Public Bodies (Overseas Matters) BillMy Lords, this has been a wonderful debate, but the advisory speaking time is seven minutes. I am looking forward to seeing all noble Lords again in Committee, so please try to…20 Feb 2024HANSARDLung Cancer MedicinesMy Lords, the Medicines and Healthcare products Regulatory Agency is engaging with Takeda Pharmaceuticals to ensure that, where appropriate, patients receiving Mobocertinib have…14 Feb 2024HANSARDLung Cancer MedicinesMy Lords, I share the noble Lord’s disappointment that the company has taken the decision to withdraw Mobocertinib from the market globally. I understand that this decision was…14 Feb 2024HANSARDLung Cancer MedicinesMy noble friend raises a very important point about communication. When patients are in receipt of drugs and surgery, it is a very vulnerable time, and it is important they are…14 Feb 2024HANSARDLung Cancer MedicinesI am most grateful to the noble Lord for his lifelong service to the community and to this House. He raises a very good point. On the one hand, NICE is clear that there are…14 Feb 2024HANSARDLung Cancer MedicinesThe noble Lord raises a good point, and I agree with it. Since 2016, the cancer drugs fund, worth £340 million per year, has delivered faster access for tens of thousands of NHS…14 Feb 2024